Aspen Neuroscience

News

Bambusa, Aspen, and Tang added to IPO pipeline

2026's sizeable haul of IPOs shows no signs of letting up, with three more biotechs – Bambusa, Aspen, and blank cheque firm Tang – joining the queue.

News

ADC specialist Solve raises $120m, and other biofinancings

Our round-up of biofinancings is led by a $120m round for ADC specialist Solve, with Aspen, Artios, Profluent, and Gate Bioscience also raising funds.

News

Aspen taps tech firms for digital Parkinson's trial

Aspen Neuroscience is adding a digital dimension to a study of its experimental cell therapy for Parkinson's disease, with the help of tech companies Emerald Innovations a

Bambusa, Aspen, and Tang added to IPO pipeline

ADC specialist Solve raises $120m, and other biofinancings

Aspen taps tech firms for digital Parkinson's trial

MHRA lays out its thinking on AI and medicines regulation

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks